Orocidin QR-01 Shows a Good Safety Profile in Preclinical Toxicity Study
About Orocidin Orocidin’s mission is to develop the preferred treatment against aggressive periodontitis. Our innovative therapeutic agent, QR-01, distinguishes itself through its unique ability to ...
HeartCore to Expand its Go IPO Consulting Services into South Korea
NEW YORK and TOKYO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company ...